Clinical Trial

Efficacy of IPL, an Anti-redness Dermocosmetic, and Their Combination in the Treatment of Rosacea

Completed
View on ClinicalTrials.gov →
Summary
This study compares three approaches to treating persistent facial redness in adults with erythematotelangiectatic rosacea: intense pulsed light (IPL) treatment alone, a professional anti-redness dermocosmetic skincare regimen alone, and the combination of both. The main question the study aims to answer is which of these three strategies is more effective at reducing facial redness, using both clinician grading and objective skin-imaging tools that measure redness and skin texture before and after treatment.
Trial Details
NCT Number NCT07729540
Lead Sponsor Medical University of Silesia
Collaborators: Synchroline/Cantabria Labs
Conditions Rosacea
Enrollment 60 participants
Start Date 2025-09-29
Primary Completion 2026-04-30 (estimated)
Study Completion 2026-04-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-27